Prasinezumab
Modify Date: 2025-09-19 09:40:40
Prasinezumab structure
|
Common Name | Prasinezumab | ||
|---|---|---|---|---|
| CAS Number | 1960462-19-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PrasinezumabPrasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research[1]. |
| Name | Prasinezumab |
|---|
| Description | Prasinezumab (PRX 002) is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Prasinezumab has the potential for Parkinson's disease research[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Prasinezumab 针对人 α-突触核蛋白羧基末端的表位。 Prasinezumab 以高亲和力与人类聚集的 α-突触核蛋白结合[1]。 |
| References |
| No Any Chemical & Physical Properties |